However when thresholds for classifying patients as positive and negative were used, 33% of tumours ERCC1 negative by RTqPCR were IHC positive and 32% IHC-negative tumors were classed as ERCC1 positive using RTqPCR [11]. This evidence concerns the gene ERCC1 and neoplasm.